Want to see KCDMY full AI Analyst Report?
KCDMY Stock Chart & Stats
$10.44
-$0.11(-1.53%)
At close: 4:00 PM EST
$10.44
-$0.11(-1.53%)
Day’s Range― - ―
52-Week Range$9.10 - $12.55
Previous CloseN/A
Volume7.86K
Average Volume (3M)6.96K
Market Cap
$6.47B
Enterprise Value$124.92B
Total Cash (Recent Filing)$20.18B
Total Debt (Recent Filing)$31.03B
Price to Earnings (P/E)14.9
Beta0.21
Next Earnings
Jul 21, 2026EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend Yield4.7%
Share Statistics
EPS (TTM)12.85
Shares Outstanding312,725,340
10 Day Avg. Volume0
30 Day Avg. Volume6,964
Financial Highlights & Ratios
PEG Ratio-2.43
Price to Book (P/B)15.97
Price to Sales (P/S)2.23
P/FCF Ratio19.02
Enterprise Value/Market Cap19.30
Enterprise Value/Revenue2.24
Enterprise Value/Gross Profit5.66
Enterprise Value/Ebitda8.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.77
Revenue Forecast (FY)$3.33B
Bulls Say, Bears Say
Bulls Say
Margin StrengthSustained gross margins near 39% and net margins around 13.7% indicate durable pricing power and operational discipline in core tissue and personal-care categories. High margins support reinvestment, dividend capacity and resilience through cyclical input-cost swings.
Cash ConversionFree cash flow converting at roughly 70%–80% of net income shows strong cash-generation from operations across the business. This reliable cash conversion underpins funding for capex, dividends and strategic initiatives, enhancing long-term financial flexibility despite short-term variability.
Liquidity & Operational ActionsRobust liquidity (MXN 20.4B cash, net debt/EBITDA ~0.9x), a MXN 10B debt issuance to extend maturities, and MXN 450M quarter cost savings materially lower refinancing and operational risks. These actions increase balance-sheet optionality for M&A or capex over the medium term.
Bears Say
High Leverage / Thin EquityA high absolute debt load (~MXN 31B) versus a very thin equity base (~MXN 2.5B) leaves limited capitalization cushion. Debt-to-equity near ~3.0x increases sensitivity to earnings volatility or refinancing stress and raises financial risk if margins or cash flow deteriorate.
Weakening Free Cash Flow TrendAlthough cash conversion is normally strong, free cash flow declined in 2025 and on a TTM basis, and operating cash flow covers only about 63% of total debt. This reducing FCF trend constrains reinvestment, debt paydown and increases vulnerability to higher funding costs.
Input Cost & Pricing RisksExposure to commodity and FX swings plus an earlier, larger promotional season can erode price realization. Management’s modest ~4% increases may be offset by promotional activity and oil-driven raw-material spikes, pressuring margins and earnings durability if costs persist.
Kimberly-Clark de Mexico SAB de CV News
KCDMY FAQ
What was Kimberly-Clark de Mexico SAB de CV’s price range in the past 12 months?
Kimberly-Clark de Mexico SAB de CV lowest stock price was $9.10 and its highest was $12.55 in the past 12 months.
What is Kimberly-Clark de Mexico SAB de CV’s market cap?
Kimberly-Clark de Mexico SAB de CV’s market cap is $6.47B.
When is Kimberly-Clark de Mexico SAB de CV’s upcoming earnings report date?
Kimberly-Clark de Mexico SAB de CV’s upcoming earnings report date is Jul 21, 2026 which is in 19 days.
How were Kimberly-Clark de Mexico SAB de CV’s earnings last quarter?
Kimberly-Clark de Mexico SAB de CV released its earnings results on Apr 21, 2026. The company reported $0.196 earnings per share for the quarter, beating the consensus estimate of $0.195 by $0.001.
Is Kimberly-Clark de Mexico SAB de CV overvalued?
According to Wall Street analysts Kimberly-Clark de Mexico SAB de CV’s price is currently Overvalued.
Does Kimberly-Clark de Mexico SAB de CV pay dividends?
Kimberly-Clark de Mexico SAB de CV pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 4.7%. See more information on Kimberly-Clark de Mexico SAB de CV dividends here
What is Kimberly-Clark de Mexico SAB de CV’s EPS estimate?
Kimberly-Clark de Mexico SAB de CV’s EPS estimate is 0.2.
How many shares outstanding does Kimberly-Clark de Mexico SAB de CV have?
Kimberly-Clark de Mexico SAB de CV has 312,725,340 shares outstanding.
What happened to Kimberly-Clark de Mexico SAB de CV’s price movement after its last earnings report?
Kimberly-Clark de Mexico SAB de CV reported an EPS of $0.196 in its last earnings report, beating expectations of $0.195. Following the earnings report the stock price went up 1.199%.
Which hedge fund is a major shareholder of Kimberly-Clark de Mexico SAB de CV?
Currently, no hedge funds are holding shares in KCDMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kimberly-Clark de Mexico SAB de CV Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.99%
12-Months-Change
Fundamentals
Return on Equity
161.39%
Trailing 12-Months
Asset Growth
35.16%
Trailing 12-Months
Company Description
Kimberly-Clark de Mexico SAB de CV
Kimberly-Clark de México, S. A. B. de C. V., through its subsidiaries, manufactures and distributes a wide array of disposable consumer goods for everyday use across Mexico. The company's diverse product offering spans several categories: infant care, featuring diapers, training pants, swim diapers, wet wipes, shampoos, soaps, and feeding items; beauty products, including various bar and liquid soaps, micellar water, and makeup removal wipes; adult care products like protective underwear, pads, and prefolded items; household paper goods such as toilet paper, napkins, facial tissues, and paper towels; and feminine hygiene essentials like pads, panty liners, tampons, and intimate wipes. Additionally, it supplies professional and industrial clients with dispensers, jumbo roll toilet papers, various towels, antibacterial gel, disinfecting spray, facemasks, and specialized cleaning cloths. These offerings are sold predominantly under popular brands including Huggies, KleenBebe, Pull-Ups, Evenflo, Kleenex, Kotex, Depend, Cottonelle, Pétalo, Suavel, Vogue, Sanitas, Marli y Kimlark, Jabón Escudo Antibacterial, and Jabones Kleenex. The company also engages in exporting its products. Kimberly-Clark de México, S. A. B. de C. V. was founded in 1925 and operates from its base in Mexico City, Mexico.
KCDMY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a generally positive performance with record revenue, double-digit increases in gross profit, operating profit, EBITDA and net income, meaningful cost-savings (MXN 450 million) and strong liquidity metrics. Management acknowledged near-term risks including SG&A growth, higher financing cost, FX and commodity volatility (notably an oil-driven raw material cost shock) and a challenging promotional environment that could affect price realization. Operationally, Consumer Products outperformance, sequential recoveries in Away-from-Home and Exports, progress on the KCM+ strategy, and a strengthened debt maturity profile underpin confidence in continued improvement through the year despite transitory cost headwinds.View all KCDMY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.10% Other Institutional Investors
99.79% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---